1-5 of 5
Luc Xerri
Close
Sort by
Journal Articles

Genomic and microenvironmental landscape of stage I follicular lymphoma, compared with stage III/IV

G. Tjitske Los-de Vries, Wendy B. C. Stevens, Erik van Dijk, Carole Langois-Jacques, Andrew J. Clear, Phylicia Stathi, Margaretha G. M. Roemer, Matias Mendeville, Nathalie J. Hijmering, Birgitta Sander, Andreas Rosenwald, Maria Calaminici, Eva Hoster, Wolfgang Hiddemann, Philippe Gaulard, Gilles Salles, Heike Horn, Wolfram Klapper, Luc Xerri, Catherine Burton, Reuben M. Tooze, Alexandra G. Smith, Christian Buske, David W. Scott, Yasodha Natkunam, Ranjana Advani, Laurie H. Sehn, John Raemaekers, John Gribben, Eva Kimby, Marie José Kersten, Delphine Maucort-Boulch, Bauke Ylstra, Daphne de Jong
Journal: Blood Advances
Blood Adv (2022) 6 (18): 5482–5493.
https://doi.org/10.1182/bloodadvances.2022008355
Published: 2022
Includes: Supplemental data
Journal Articles

Functional characterization of PD1 + TIM3 + tumor-infiltrating T cells in DLBCL and effects of PD1 or TIM3 blockade

Mikaël Roussel, Kieu-Suong Le, Clémence Granier, Francisco Llamas Gutierrez, Etienne Foucher, Simon Le Gallou, Céline Pangault, Luc Xerri, Vincent Launay, Thierry Lamy, Eric Tartour, Daniel Olive, Thierry Fest
Journal: Blood Advances
Blood Adv (2021) 5 (7): 1816–1829.
https://doi.org/10.1182/bloodadvances.2020003080
Published: 2021
Includes: Supplemental data
Journal Articles

Lenalidomide/rituximab induces high molecular response in untreated follicular lymphoma: LYSA ancillary RELEVANCE study

Clinical Trials & Observations
Marie-Helene Delfau-Larue, Marie-Laure Boulland, Asma Beldi-Ferchiou, Pierre Feugier, Hervé Maisonneuve, Rene-Olivier Casasnovas, François Lemonnier, Gian Matteo Pica, Roch Houot, Loic Ysebaert, Hervé Tilly, Jean-Claude Eisenmann, Steven Le Gouill, Vincent Ribrag, Pascal Godmer, Sylvie Glaisner, Guillaume Cartron, Luc Xerri, Gilles André Salles, Thierry Fest, Franck Morschhauser
Journal: Blood Advances
Blood Adv (2020) 4 (14): 3217–3223.
https://doi.org/10.1182/bloodadvances.2020001955
Published: 2020
Includes: Supplemental data
Journal Articles

CXCR5 and ICOS expression identifies a CD8 T-cell subset with T FH features in Hodgkin lymphomas

Kieu-Suong Le, Patricia Amé-Thomas, Karin Tarte, Françoise Gondois-Rey, Samuel Granjeaud, Florence Orlanducci, Etienne D. Foucher, Florence Broussais, Reda Bouabdallah, Thierry Fest, Dominique Leroux, Sapna Yadavilli, Patrick A. Mayes, Luc Xerri, Daniel Olive
Journal: Blood Advances
Blood Adv (2018) 2 (15): 1889–1900.
https://doi.org/10.1182/bloodadvances.2018017244
Published: 2018
Includes: Supplemental data
Journal Articles

Mutation load and an effector T-cell gene signature may distinguish immunologically distinct and clinically relevant lymphoma subsets

Christopher R. Bolen, Ronald McCord, Sarah Huet, Garrett M. Frampton, Richard Bourgon, Fabrice Jardin, Peggy Dartigues, Elizabeth A. Punnoose, Edith Szafer-Glusman, Luc Xerri, Pierre Sujobert, Gilles Salles, Jeffrey M. Venstrom
Journal: Blood Advances
Blood Adv (2017) 1 (22): 1884–1890.
https://doi.org/10.1182/bloodadvances.2016000786
Published: 2017
Includes: Supplemental data